Resistant starch: A functional food that prevents DNA damage and chemical carcinogenesis

Genetics and Molecular Research

Volumn 14, Issue 1, 2015, Pages 1679-1691

  Navarro, S D ^a   Mauro, M O ^a   Pesarini, J R ^a   Ogo, F M ^b   Oliveira, R J ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Anticarcinogenicity; Antigenotoxicity; Antimutagenicity; Chemoprevention; Green banana

Indexed keywords

RESISTANT STARCH; STARCH; UNCLASSIFIED DRUG; DIMAZINE; DIMETHYLHYDRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BANANA; CANCER PREVENTION; CANCER THERAPY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; GENOTOXICITY; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENESIS; MUTAGENIC ACTIVITY; NONHUMAN; OUTCOME ASSESSMENT; ABERRANT CRYPT FOCUS; ADMINISTRATION AND DOSAGE; ANIMAL; CARCINOGENESIS; CHEMISTRY; COLORECTAL NEOPLASMS; COMET ASSAY; DIETARY FIBER; DISEASE MODEL; DRUG EFFECTS; FLOUR; FOOD HANDLING; FUNCTIONAL FOOD; MUSA;

ANIMALIA;

ABERRANT CRYPT FOCI; ANIMALS; CARCINOGENESIS; COLORECTAL NEOPLASMS; COMET ASSAY; DIETARY FIBER; DIMETHYLHYDRAZINES; DISEASE MODELS, ANIMAL; DNA DAMAGE; FLOUR; FOOD HANDLING; FUNCTIONAL FOOD; MALE; MICE; MICRONUCLEUS TESTS; MUSA; STARCH;

EID: 84924301416     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.March.6.14     Document Type: Article

References (38)

1. Asp NG and Björck I (1992). Resistant starch. Trends Food Sci. Technol. 3: 111-114.
2. Bergmann MM, Bodzioch M, Bonet ML, Defoort C, et al. (2006). Bioethics in human nutrigenomics research: European Nutrigenomics Organisation workshop report. Br. J. Nutr. 95: 1024-1027.
3. Bird RP (1987). Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37: 147-151.
4. Bolognani F, Rumney CJ, Pool-Zobel BL and Rowland IR (2001). Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur. J. Nutr. 40: 293-300.
5. Borges VC (2000). Alimentos Funcionais: Prebióticos, Probióticos, Fitoquímicos e Simbióticos. In: Nutrição Oral, Enteral e Parenteral na Prática Clínica (Waitzberg DL, ed.). Atheneu, São Paulo, 1495-1509.
6. Burns AJ and Rowland IR (2004). Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 551: 233-243.
7. Champ M and Faisant N (1996). Resistant starch: analytical and physiological aspects. Bol. SBCTA 30: 37-43.
8. Chao A, Thun MJ, Connell CJ, McCullough ML, et al. (2005). Meat consumption and risk of colorectal cancer. JAMA 293: 172-182.
9. Cheng L and Lai MD (2003). Aberrant crypt foci as microscopic precursors of colorectal cancer. World J. Gastroenterol. 9: 2642-2649.
10. Clark MJ, Robien K and Slavin JL (2012). Effect of prebiotics on biomarkers of colorectal cancer in humans: a systematic review. Nutr. Rev. 70: 436-443.
11. De Flora S and Ferguson LR (2005). Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 591: 8-15.
12. Englyst HN, Kingman SM and Cummings JH (1992). Classification and measurement of nutritionally important starch fractions. Eur. J. Clin. Nutr. 46 (Suppl 2): S33-S50.
13. Ferguson LR (1994). Antimutagens as cancer chemopreventive agents in the diet. Mutat. Res. 307: 395-410.
14. Flagg EW, Coates RJ and Greenberg RS (1995). Epidemiologic studies of antioxidants and cancer in humans. J. Am. Coll. Nutr. 14: 419-427.
15. Haralampu SG (2000). Resistant starch-a review of the physical properties and biological impact of RS3. Carbohydr. Polym. 41: 285-292.
16. Hayashi M, Morita T, Kodama Y, Sofuni T, et al. (1990). The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245: 245-249.
17. Instituto Nacional do Câncer (2012). Estimativa2012. Available at [http://portal.saude.sp.gov.br/resources/ses/perfil?gestor/homepage/estimativas-de-incidencia-de-cancer-2012/estimativas_incidencia_cancer_2012.pdf]. Accessed September 25, 2014.
18. Instituto Nacional do Câncer (2014). Estimativa2014. Available at [http://www.inca.gov.br/estimativa/2014/index.asp?ID=2]. Accessed September 25, 2014.
19. Jenkins DJ, Vuksan V, Kendall CW, Wursch P, et al. (1998). Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J. Am. Coll. Nutr. 17: 609-616.
20. Juarez-Garcia E, Agama-Acevedo E, Sáyago-Ayerdi SG, Rodríguez-Ambriz SL, et al. (2006). Composition, digestibility and application in breadmaking of banana flour. Plant Foods Hum. Nutr. 61: 131-137.
21. Kobayashi H, Sugiyama C, Morikawa Y and Hayashi M (1995). A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay. MMS Commun. 3: 103-115.
22. Liu R and Xu G (2008). Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats. Food Chem. Toxicol. 46: 2672-2679.
23. Manoharan K and Banerjee MR (1985). beta-Carotene reduces sister chromatid exchanges induced by chemical carcinogens in mouse mammary cells in organ culture. Cell Biol. Int. Rep. 9: 783-789.
24. Mauro MO, Sartori D, Oliveira RJ, Ishii PL, et al. (2011). Activity of selenium on cell proliferation, cytotoxicity, and apoptosis and on the expression of CASP9, BCL-XL and APC in intestinal adenocarcinoma cells. Mutat. Res. 715: 7-12.
25. Mauro MO, Monreal MT, Silva MT, Pesarini JR, et al. (2013). Evaluation of the antimutagenic and anticarcinogenic effects of inulin in vivo. Genet. Mol. Res. 12: 2281-2293.
26. McBain AJ and MacFarlane GT (2001). Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial ecosystems. J. Med. Microbiol. 50: 833-842.
27. Milner JA (1999). Functional foods and health promotion. J. Nutr. 129: 1395S-1397S.
28. Muir JG and O’Dea K (1992). Measurement of resistant starch: factors affecting the amount of starch escaping digestion in vitro. Am. J. Clin. Nutr. 56: 123-127.
29. Oliveira RJ, Baise E, Mauro MO, Pesarini JR, et al. (2009). Evaluation of chemopreventive activity of glutamine by the comet and the micronucleus assay in mice’s peripheral blood. Environ. Toxicol. Pharmacol. 28: 120-124.
30. Oliveira RJ, Salles MJ, da Silva AF, Kanno TY, et al. (2013). In vivo evaluation of the antimutagenic and antigenotoxic effects of beta-glucan extracted from Saccharomyces cerevisiae in acute treatment with multiple doses. Genet. Mol. Biol. 36: 413-424.
31. Pesarini JR, Zaninetti PT, Mauro MO, Carreira CM, et al. (2013). Antimutagenic and anticarcinogenic effects of wheat bran in vivo. Genet. Mol. Res. 12: 1646-1659.
32. Roberfroid MB (1993). Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit. Rev. Food Sci. Nutr. 33: 103-148.
33. Roberfroid MB (2005). Introducing inulin-type fructans. Br. J. Nutr. 93 (Suppl l 1): S13-S25.
34. Rodrigues MA, Silva LA, Salvadori DM, de Camargo JL, et al. (2002). Aberrant crypt foci and colon cancer: comparison between a short-and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz. J. Med. Biol. Res. 35: 351-355.
35. Rudolph RE, Dominitz JA, Lampe JW, Levy L, et al. (2005). Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol. Biomarkers Prev. 14: 605-608.
36. Salvadori DMF, Ribeiro LR and Fenech M (2003). Teste do Micronúcleo em Células Humanas In Vitro. In: Mutagênese Ambiental (Ribeiro LR, Salvadori DMF and Marques EL, eds.). ULBRA, Canoas, 201-219.
37. Stevens RG, Swede H and Rosenberg DW (2007). Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett. 252: 171-183.
38. Vogel EW (1982). Assessment of Chemically-Induced Genotoxic Events: Prospectives and Limitations. The Netherlands University Press, Leiden, 2-24.